Lindsay A Zilliox1,2, James W Russell3,4. 1. Department of Neurology, School of Medicine, University of Maryland, 3S-129, 110 South Paca Street, Baltimore, MD, 21201-1595, USA. 2. Maryland VA Healthcare System, Baltimore, MD, USA. 3. Department of Neurology, School of Medicine, University of Maryland, 3S-129, 110 South Paca Street, Baltimore, MD, 21201-1595, USA. JRussell@som.umaryland.edu. 4. Maryland VA Healthcare System, Baltimore, MD, USA. JRussell@som.umaryland.edu.
Abstract
PURPOSE: Diabetic neuropathy is a common and disabling disorder, and there are currently no proven effective disease-modifying treatments. Physical activity and dietary interventions in patients with diabetes and diabetic neuropathy have multiple beneficial effects and are generally low risk, which makes lifestyle interventions an attractive treatment option. We reviewed the literature on the effects of physical activity and dietary interventions on length-dependent peripheral neuropathy and cardiac autonomic neuropathy in diabetes. METHODS: The electronic database PubMed was systematically searched for original human and mouse model studies examining the effect of either dietary or physical activity interventions in subjects with diabetes, prediabetes, or metabolic syndrome. RESULTS: Twenty studies are included in this review. Fourteen studies were human studies and six were in mice. Studies were generally small with few controlled trials, and there are no widely agreed upon outcome measures. CONCLUSIONS: Recent research indicates that dietary interventions are effective in modifying diabetic neuropathy in animal models, and there are promising data that they may also ameliorate diabetic neuropathy in humans. It has been known for some time that lifestyle interventions can prevent the development of diabetic neuropathy in type 2 diabetes mellitus subjects. However, there is emerging evidence that lifestyle interventions are effective in individuals with established diabetic neuropathy. In addition to the observed clinical value of lifestyle interventions, there is emerging evidence of effects on biochemical pathways that improve muscle function and affect other organ systems, including the peripheral nerve. However, data from randomized controlled trials are needed.
PURPOSE:Diabetic neuropathy is a common and disabling disorder, and there are currently no proven effective disease-modifying treatments. Physical activity and dietary interventions in patients with diabetes and diabetic neuropathy have multiple beneficial effects and are generally low risk, which makes lifestyle interventions an attractive treatment option. We reviewed the literature on the effects of physical activity and dietary interventions on length-dependent peripheral neuropathy and cardiac autonomic neuropathy in diabetes. METHODS: The electronic database PubMed was systematically searched for original human and mouse model studies examining the effect of either dietary or physical activity interventions in subjects with diabetes, prediabetes, or metabolic syndrome. RESULTS: Twenty studies are included in this review. Fourteen studies were human studies and six were in mice. Studies were generally small with few controlled trials, and there are no widely agreed upon outcome measures. CONCLUSIONS: Recent research indicates that dietary interventions are effective in modifying diabetic neuropathy in animal models, and there are promising data that they may also ameliorate diabetic neuropathy in humans. It has been known for some time that lifestyle interventions can prevent the development of diabetic neuropathy in type 2 diabetes mellitus subjects. However, there is emerging evidence that lifestyle interventions are effective in individuals with established diabetic neuropathy. In addition to the observed clinical value of lifestyle interventions, there is emerging evidence of effects on biochemical pathways that improve muscle function and affect other organ systems, including the peripheral nerve. However, data from randomized controlled trials are needed.
Authors: M Facchini; G Malfatto; L Sala; G Silvestri; P Fontana; C Lafortuna; A Sartorio Journal: J Endocrinol Invest Date: 2003-02 Impact factor: 4.256
Authors: L Zilliox; A C Peltier; P A Wren; A Anderson; A G Smith; J R Singleton; E L Feldman; N B Alexander; J W Russell Journal: Neurology Date: 2011-03-22 Impact factor: 9.910
Authors: M Emdin; A Gastaldelli; E Muscelli; A Macerata; A Natali; S Camastra; E Ferrannini Journal: Circulation Date: 2001-01-30 Impact factor: 29.690
Authors: Patricia M Kluding; Mamatha Pasnoor; Rupali Singh; Stephen Jernigan; Kevin Farmer; Jason Rucker; Neena K Sharma; Douglas E Wright Journal: J Diabetes Complications Date: 2012-06-18 Impact factor: 2.852
Authors: Nicola Pritchard; Katie Edwards; Anthony W Russell; Bruce A Perkins; Rayaz A Malik; Nathan Efron Journal: Diabetes Care Date: 2015-01-08 Impact factor: 19.112
Authors: Joseph C Handsaker; Steven J Brown; Frank L Bowling; Glen Cooper; Constantinos N Maganaris; Andrew J M Boulton; Neil D Reeves Journal: Diabetes Care Date: 2014-11 Impact factor: 19.112
Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service Journal: Neurology Date: 1993-04 Impact factor: 9.910
Authors: Beat P Müller-Stich; Lars Fischer; Hannes G Kenngott; Matthias Gondan; Jonas Senft; Gabriella Clemens; Felix Nickel; Thomas Fleming; Peter P Nawroth; Markus W Büchler Journal: Ann Surg Date: 2013-11 Impact factor: 12.969
Authors: Brian C Callaghan; Evan L Reynolds; Mousumi Banerjee; Gulcin Akinci; Ericka Chant; Emily Villegas-Umana; Amy E Rothberg; Charles F Burant; Eva L Feldman Journal: Obesity (Silver Spring) Date: 2021-11-07 Impact factor: 5.002
Authors: Krish Chandrasekaran; Neda Najimi; Avinash R Sagi; Sushuma Yarlagadda; Mohammad Salimian; Muhammed Ikbal Arvas; Ahmad F Hedayat; Yanni Kevas; Anand Kadakia; James W Russell Journal: Int J Mol Sci Date: 2022-04-28 Impact factor: 6.208
Authors: Scott M Williams; Aikaterini Eleftheriadou; Uazman Alam; Daniel J Cuthbertson; John P H Wilding Journal: Diabetes Ther Date: 2019-09-24 Impact factor: 2.945
Authors: Byron M Perrin; Anita Raspovic; Cylie M Williams; Stephen M Twigg; Jonathan Golledge; Emma J Hamilton; Anna Crawford; Carol Hargreaves; Jaap J van Netten; Nytasha Purcell; Peter A Lazzarini Journal: BMJ Open Diabetes Res Care Date: 2021-11
Authors: Byron M Perrin; Jessica Southon; Jane McCaig; Isabelle Skinner; Timothy C Skinner; Michael I C Kingsley Journal: Medicina (Kaunas) Date: 2021-12-30 Impact factor: 2.430